By Dr Shane Oliver, Chief Economist and Head of Investment Strategy at AMP. Investment markets and key developments Global ...
(“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath ® , a patented, FDA-cleared drug-delivery device ...
Sanofi (ENXTPA:SAN) has expanded its rare disease collaboration with Mirecule, focusing on next generation treatments for neuromuscular conditions. The company has deepened its relationship with ...
Speaker-designate Sam Garrison ‘stunned’ by racist campaigning in HD 87 ” via Peter Schorsch of Florida Politics — House Spe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results